Abstract:Ai-Yuan Xiu, 1 Qian Ding, 2 Zhen Li, 2 Chun-Qing Zhang 1, 2 1 Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, People's Republic of China; 2 Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, People's Republic of China Correspondence: Chun-Qing Zhang Department of Gastroenterology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, 324 Jingwu Weiqi Road, Jinan, 250021, People's Republic of China Tel +86 5 316 877 3293 Fax +86 5 318 790 6348 Email Purpose: To investigate the effect of doxazosin on autophagy and the activation of hepatic stellate cells (HSCs) in vivo and in vitro and determine the underlying mechanism. Methods: In vivo, a mouse liver fibrosis model was induced by the intraperitoneal injection of carbon tetrachloride (CCl 4 ). Doxazosin was administered at doses of 2.5, 5 and 10 mg/(kg&astday) by gavage. After 20 weeks, blood and liver tissues were collected for serological and histological analysis, respectively. Blood analysis, hematoxylin and eosin (HE) staining, Masson's trichrome staining, immunohistochemistry and immunofluorescence staining were used to measure the extent of liver fibrosis in model and control mice. In vitro, the human HSC cell line LX-2 was cultured and treated with different doses of doxazosin for the indicated times. The effects of doxazosin on LX-2 cell proliferation and migration were examined by Cell Counting Kit-8 (CCK-8) and Transwell assays, respectively. The number of autophagosomes in LX-2 cells was observed by transmission electron microscopy (TEM). Infection with green fluorescent protein (GFP)-LC3B adenovirus, GFP-red fluorescent protein (RFP)-LC3B adenovirus and mCherry-EGFP-LC3 adeno-associated virus was performed to examine changes in autophagic flux in vitro and in vivo. Cell apoptosis was measured by flow cytometry in vitro and by TUNEL assays both in vitro and in vivo. Immunoblotting was performed to evaluate the expression levels of proteins related to fibrosis, autophagy, apoptosis, and phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR). Results: Doxazosin inhibited HSC proliferation and migration. HSC activation was attenuated by doxazosin in a concentration-dependent manner in vivo and in vitro. Doxazosin also blocked autophagic flux and induced apoptosis in HSCs. In addition, the PI3K/Akt/mTOR pathway was activated by doxazosin and regulated fibrosis, autophagy and apoptosis in HSCs. Conclusion: The study confirmed that doxazosin could inhibit autophagy by activating the PI3K/Akt/mTOR signaling pathway and attenuate liver fibrosis. Keywords: doxazosin, liver fibrosis, autophagy, apoptosis, mTOR Liver fibrosis is a complicated pathophysiological process that serves as an intermediate stage for various chronic liver diseases, including liver cirrhosis. 1 Portal hypertension (PHT) and hepatic failure usually occur in the late stage of liver cirrhosis. 2 Although strategies for the diagnosis and treatment of liver cirrhosis have improved, this disease still causes more than one million deaths each year worldwide. 3 Thus far, apart from ameliorating the underlying cause or performing liver transplantation, no effective clinical therapies are available to inhibit the pathological progression of liver fibrosis, 4 and safe and effective drugs are urgently needed. The activation of hepatic stellate cells (HSCs) is crucial for liver fibrogenesis because they transdifferentiate into myofibroblasts, which are the primary cells responsible for synthesizing the extracellular matrix (ECM) in the liver. 5 Activated HSCs can produce alpha smooth muscle actin (α-SMA) and type I collagen (COL1, formed by two molecules of COL1A1 and one molecule of COL1A2), 6 , 7 ultimately leading to an imbalance in ECM production and degradation. Autophagy is a crucial intracellular pathway, through which damaged organelles and impaired proteins are degraded to supply eukaryotic cells with energy to maintain homeostasis. 8 Previous studies have shown that the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway plays an important role in regulating cellular autophagy, including that in HSCs. 9–11 Autophagy can provide energy for HSC activat -Abstract Truncated-

MP06-13 AUTOPHAGY PROMOTES PROSTATIC FIBROBLAST ACTIVATION IN PROGRESSION OF BPH BY MODULATION OF LIPID METABOLISM

Hypoxia-induced Autophagy Promotes Human Prostate Stromal Cells Survival and ER-stress

Abstract A06: Cholesteryl Ester Accumulation Induced by PTEN Loss and PI3K/AKT Activation Underlies Human Prostate Cancer Aggressiveness

Activation of the cGMP/PKG/ERK signaling pathway associated with PDE5Is inhibits fibroblast activation by downregulating autophagy in early progressive benign prostatic hyperplasia

MP06-09 SENESCENT PROSTATIC EPITHELIAL CELLS INDUCE PROLIFERATION OF FIBROBLAST DURING THE PROGRESSION OF BENIGN PROSTATIC HYPERPLASIA

Aspartoacylase Suppresses Prostate Cancer Progres-Sion by Blocking LYN Activation

Autophagy in benign prostatic hyperplasia: insights and therapeutic potential

Inhibition Of Androgen Induces Autophagy In Benign Prostate Epithelial Cells

Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway

Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia

M2 Macrophage-Mediated Interleukin-4 Signalling Induces Myofibroblast Phenotype During the Progression of Benign Prostatic Hyperplasia

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis

S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate

MP44-10 CD8+ T CELLS PROMOTE PROLIFERATION OF BENIGN PROSTATIC HYPERPLASIA EPITHELIAL CELLS IN THE CONDITION OF LOW ANDROGEN VIA MODULATION OF CCL5 -> STAT5 -> CYCLIN D1 SIGNALING

Immune Cell Proinflammatory Microenvironment and Androgen-Related Metabolic Regulation During Benign Prostatic Hyperplasia in Aging

Correlation Between Cholinergic Innervation, Autophagy, and Etiopathology of Benign Prostatic Hyperplasia

Infiltrating lipid-rich macrophage subpopulations identified as a regulator of increasing prostate size in human benign prostatic hyperplasia

Mp31-04 cd8+ t cells promote proliferation of benign prostatic hyperplasia epithelial cells in the condition of low androgen

Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate

Extracellular vesicles mediate OxLDL-induced stromal cell proliferation in Benign Prostatic Hyperplasia

The Effects of Cordycepin on Benign Prostatic Hyperplasia through Autophagy Activation in BPH-1 Cell Line